09.09.2009 5:14 pm
KV sets record date for shareholder action on bylaws
St. Louis Post-Dispatch
Marc Hermelin - the ousted head of KV Pharmaceutical Co. - and other key shareholders inched closer to implementing their proposed changes to the bylaws of the Brentwood-based drug maker.
On Wednesday, KV announced it had set Sept. 11 as the record date…
